Your session is about to expire
← Back to Search
Robotic Surgery
Robotic Surgery for Prostate Cancer
N/A
Waitlist Available
Led By Steven Clinton, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
ARM B: Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center. Ability to understand and willingness to sign the written informed consent document. 18 years and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 years
Awards & highlights
Study Summary
This trial looks at the surgical outcomes of men who had robot-assisted surgery to remove their prostate.
Who is the study for?
This trial is for men aged 18 or older with prostate cancer who are either scheduled to undergo or have already undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, Ohio State University Medical Center.Check my eligibility
What is being tested?
The study is analyzing the surgical outcomes of patients who have had their prostates removed using a robot-assisted technique known as robotic radical prostatectomy.See study design
What are the potential side effects?
While this study focuses on outcomes rather than side effects, typical risks of robotic prostate surgery may include urinary incontinence, erectile dysfunction, and general surgical risks like infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18, have prostate cancer, and will have surgery at The Arthur G. James Cancer Hospital.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 20 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Collect and analyze descriptive characteristics of patient population and summarize patient outcome data.
Secondary outcome measures
Correlate the patient characteristics to the surgical outcomes.
Determine the overall survival
Determine the rate of local recurrence in patients undergoing robotic prostatectomy and compare these metrics to historical controls.
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm BExperimental Treatment1 Intervention
Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center .
Group II: Arm AActive Control1 Intervention
Patients with prostate cancer who have undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
288,636 Total Patients Enrolled
9 Trials studying Prostate Cancer
639 Patients Enrolled for Prostate Cancer
Steven Clinton, MDPrincipal InvestigatorOhio State University
6 Previous Clinical Trials
305 Total Patients Enrolled
3 Trials studying Prostate Cancer
169 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 18, have prostate cancer, and will have surgery at The Arthur G. James Cancer Hospital.I had prostate cancer surgery at The Arthur G. James Cancer Hospital and am willing to sign consent.
Research Study Groups:
This trial has the following groups:- Group 1: Arm A
- Group 2: Arm B
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for enrolment in this study?
"According to information posted on clinicaltrials.gov, this particular medical study is not actively recruiting; the trial was first published in September 2008 with its last update occurring in November 2020. Nevertheless, there are 1,321 alternative studies that are presently open for enrollment."
Answered by AI
Share this study with friends
Copy Link
Messenger